stockrowAlkermes plc
ALKS Healthcare Drug Manufacturers Specialty & Generic
Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.
- Revenue
- +21.8%
- EPS
- −80.6%
- Free cash flow
- +6.78%
Quarter to September 2026, against a year earlier
Follow ALKS
Alert me
Alkermes plc (ALKS) EV/FCF
As of 5 November 2026, Alkermes plc (ALKS) trades at a EV/FCF of 36.0×. Over the past ten years it has ranged from −1,353× (August 2018) to 1,117× (October 2018); the current reading is higher than 70% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 7.4× | (29.71%) |
| FY2024 | 10.6× | (12.52%) |
| FY2023 | 12.1× | — |
| FY2022 | −211× | — |
| FY2021 | 43.8× | (30.11%) |
| FY2020 | 62.7× | — |
| FY2019 | −152× | — |
| FY2018 | 132× | — |
| FY2017 | −242× | — |
| FY2016 | −71.8× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 33.0× | (23.37%) |
| Jun 2026 | 43.1× | 38.65% |
| Mar 2026 | 31.1× | 318.26% |
| Dec 2025 | 7.4× | (11.67%) |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −158× |
| LNTH Lantheus Holdings, Inc. compare | 16.6× |
| LQDA Liquidia Corporation compare | 25.6× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 32.2× |
| ALKS Alkermes plc | 36.0× |
| ELAN Elanco Animal Health Incorporated compare | 42.7× |
| HIMS Hims & Hers Health, Inc. compare | 73.6× |
| RDY Dr. Reddy's Laboratories Ltd compare | 126× |
| SUPN Indivior Pharmaceuticals Inc. compare | 138× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ALKS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement